• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Erythema (1840); Nausea (1970); Numbness (2415); Swelling/ Edema (4577)
Event Date 04/26/2022
Event Type  Injury  
Event Description
Received synvisc in left knee the morning of (b)(6) 2022.That evening entire leg began to swell and numbness occurred from toes and pad left foot and traveled on left lateral aspect into left hip.Symptoms continued to intensify.I also experienced queasy stomach, pins and needle sensation in foot into leg.On (b)(6) i was no longer able to wear a shoe on left foot due to swelling.Edema was +2 pitting edema in foot into calf.I was afebrile but was concerned about redness on left lateral and medial aspect of ankle.I was unable to stand on left leg due to pain and awakened several times during the night due to pain.I was unable to reach provider who injected synvisc, therefore scheduled appointment with pa at pcp office.A nurse from orthopedic provider called afterwards.I explained symptoms to him and told him i had scheduled pa appointment.Pa was unfamiliar with synvisc.She wrapped ace wrap around foot and leg, advised elevating and icing leg.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key14282559
MDR Text Key290793110
Report NumberMW5109493
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2022
Was Device Available for Evaluation? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-